์กฐ์˜์ œ ์œ ๋ฐœ ์‹ ์†์ƒ ์˜ˆ๋ฐฉ / Contrast-induced nephropathy prevention

์ •์˜

์กฐ์˜์ฆ๊ฐ• CT ์ „ํ›„ ์‹ ๊ธฐ๋Šฅ ์ €ํ•˜ ํ™˜์ž์—์„œ ์กฐ์˜์ œ ๊ด€๋ จ ์‹ ์†์ƒ(CIN)์„ ์˜ˆ๋ฐฉํ•˜๊ธฐ ์œ„ํ•œ ์ „์ฒ˜์น˜ ๊ฐœ๋….

์ž„์ƒ ํ•ต์‹ฌ

eGFR 60 ๋ฏธ๋งŒ๋ถ€ํ„ฐ ์ „์ฒ˜์น˜๋ฅผ ๊ณ ๋ คํ•œ๋‹ค๋Š” ๋ฉ”๋ชจ๊ฐ€ ์žˆ๋‹ค. ๊ธฐ์กด์˜ creatinine 1.5 ๊ธฐ์ค€์€ ์ทจ์†Œ์„ ์œผ๋กœ ํ‘œ์‹œ๋˜์–ด ์žˆ์–ด eGFR ๊ธฐ์ค€์ด ๊ฐ•์กฐ๋œ๋‹ค. Normal saline์€ isotonic์œผ๋กœ ํ˜ˆ๊ด€ ๋‚ด์— ๋จธ๋ฌด๋ฅด๋Š” ์„ฑ๊ฒฉ ๋•Œ๋ฌธ์— ์‚ฌ์šฉ๋œ๋‹ค. N-acetylcysteine์€ ํ•ญ์‚ฐํ™” ๋ฐ ์‹ ํ˜ˆ๋ฅ˜ ์ฆ๊ฐ€ ๋ชฉ์ ์œผ๋กœ ์–ธ๊ธ‰๋œ๋‹ค.

์ง„๋‹จ

์กฐ์˜ CT ์ „ eGFR๋ฅผ ํ™•์ธํ•œ๋‹ค. ์กฐ์˜์ฆ๊ฐ• CT๋Š” ํ•˜๋ฃจ ํ•œ ๋ฒˆ๋งŒ ์ฐ์„ ์ˆ˜ ์žˆ์œผ๋‹ˆ ํ•„์š”ํ•œ ๋ถ€์œ„๋ฅผ ๊ณ ๋ฏผํ•ด ํ•œ ๋ฒˆ์— ์ดฌ์˜ํ•˜๋ผ๋Š” ์‹ค๋ฌด ๋ฉ”๋ชจ๊ฐ€ ์žˆ๋‹ค. Non-enhance CT๋Š” stone, bone, blood ํ‰๊ฐ€์—, enhance CT๋Š” ์—ผ์ฆ, ๋†์–‘, ์ข…์–‘, ํ˜ˆ๊ด€, ์™ธ์ƒ ํ‰๊ฐ€์— ์–ธ๊ธ‰๋œ๋‹ค.

์น˜๋ฃŒ

์ „์ฒ˜์น˜๋กœ N/S 200โ€“300 mL push์™€ Meteran(N-acetylcysteine, NAC)์ด ์–ธ๊ธ‰๋œ๋‹ค. ์กฐ์˜์ œ allergy ์‹œ pheniramine(AH1)์ด ์–ธ๊ธ‰๋œ๋‹ค.

์ถœ์ฒ˜

Raw notion page: ์ฒ˜๋ฐฉ.

๐ŸŒฑ ์ถœ์ฒ˜ raw


๋ณธ ๋ฌธ์„œ๋Š” ํ•™์Šตยท์ฐธ๊ณ ์šฉ์ด๋ฉฐ ์‹ค์ œ ์ง„๋ฃŒ ๊ฒฐ์ •์€ ์ž„์ƒ์˜์˜ ํŒ๋‹จ์ž…๋‹ˆ๋‹ค.